Transcanal Endoscopic Management of Middle Ear Paragangliomas.
Journal
Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology
ISSN: 1537-4505
Titre abrégé: Otol Neurotol
Pays: United States
ID NLM: 100961504
Informations de publication
Date de publication:
01 09 2023
01 09 2023
Historique:
medline:
18
8
2023
pubmed:
28
7
2023
entrez:
28
7
2023
Statut:
ppublish
Résumé
To evaluate the clinical and audiological outcomes of transcanal endoscopic resection of middle ear paragangliomas. Retrospective multicenter study. Tertiary referral center and private otology clinic. Patients who underwent transcanal endoscopic surgery between January 2015 and September 2020. Transcanal endocope-assisted resection of middle ear paragangliomas. Demographic data. Twenty-three patients (2 men, 21 women) with a mean (standard deviation [SD]) age of 50.5 (11.8) years and stage 1 or 2 disease were included in the study. The mean follow-up time was 2.7 years (range, 1-5 yr). Preoperatively, the mean (SD) air-conduction threshold was 33.8 (17.9) dB, and the mean (SD) air-bone gap was 13.1 (13.9) dB. Postoperatively, the mean (SD) air-conduction threshold was 25.7 (10.2) dB, the mean (SD) air-bone gap was 6.3 (6.1) dB. The mean (SD) hospital stay was 27.7 (9.9) hours. No tumor regrowth was detected on magnetic resonance imaging during postoperative follow-up. Endoscopic transcanal tumor resection is effective and feasible in the treatment of stage 1 and 2 tumors and is associated with short operative time, low risk of perioperative and postoperative complications, and rapid discharge.
Identifiants
pubmed: 37505072
doi: 10.1097/MAO.0000000000003957
pii: 00129492-990000000-00353
doi:
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
798-803Informations de copyright
Copyright © 2023, Otology & Neurotology, Inc.
Déclaration de conflit d'intérêts
The authors disclose no conflicts of interest.
Références
Weissman JL, Hirsch BE. Beyond the promontory: The multifocal origin of glomus tympanicum tumors. AJNR Am J Neuroradiol 1998;19:119–22.
Sweeney AD, Carlson ML, Wanna GB, et al. Glomus tympanicum tumors. Otolaryngol Clin North Am 2015;48:293–304.
Lee CC, Pan DH, Wu JC, et al. Gamma knife radiosurgery for glomus jugulare and tympanicum. Stereotact Funct Neurosurg 2011;89:291–8.
Liscak R, Urgosik D, Chytka T, et al. Leksell gamma knife radiosurgery of the jugulotympanic glomus tumor: Long-term results. J Neurosurg 2014;121:198–202.
Scheick SM, Morris CG, Amdur RJ, et al. Long-term outcomes after radiosurgery for temporal bone paragangliomas. Am J Clin Oncol 2018;41:223–6.
Carlson ML, Sweeney AD, Pelosi S, et al. Glomus tympanicum: A review of 115 cases over 4 decades. Otolaryngol Head Neck Surg 2015;152:136–42.
Jackson CG, Glasscock ME 3rd, Harris PF. Glomus tumors. Diagnosis, classification, and management of large lesions. Arch Otolaryngol 1982;108:401–10.
Sanna M, Fois P, Pasanisi E, Russo A, Bacciu A. Middle ear and mastoid glomus tumors (glomus tympanicum): An algorithm for the surgical management. Auris Nasus Larynx 2010;37:661–8.
Alicandri-Ciufelli M, Marchioni D, Kakehata S, et al. Endoscopic management of attic cholesteatoma: Long-term results. Otolaryngol Clin North Am 2016;49:1265–70.
Marchioni D, Soloperto D, Rubini A, et al. Endoscopic exclusive transcanal approach to the tympanic cavity cholesteatoma in pediatric patients: Our experience. Int J Pediatr Otorhinolaryngol 2015;79:316–22.
Surmelioglu O, Ozdemir S, Tarkan O, et al. Endoscopic versus microscopic stapes surgery. Auris Nasus Larynx 2017;44:253–7.
Iannella G, Marcotullio D, Re M, et al. Endoscopic vs microscopic approach in stapes surgery: Advantages in the middle ear structures visualization and Trainee's point of view. J Int Adv Otol 2017;13:14–20.
Orhan KS, Polat B, Çelik M, et al. Endoscopic-assisted cochlear implantation: A case series. J Int Adv Otol 2016;12:337–40.
Güneri EA, Olgun Y. Endoscope-assisted cochlear implantation. Clin Exp Otorhinolaryngol 2018;11:89–95.
Killeen DE, Wick CC, Hunter JB, et al. Endoscopic management of middle ear paragangliomas: A case series. Otol Neurotol 2017;38:408–15.
Marchioni D, Alicandri-Ciufelli M, Gioacchini FM, Bonali M, Presutti L. Transcanal endoscopic treatment of benign middle ear neoplasms. Eur Arch Otorhinolaryngol 2013;270:2997–3004.
Fermi M, Ferri G, Bayoumi Ebaied T, et al. Transcanal endoscopic management of glomus tympanicum: Multicentric case series. Otol Neurotol 2021;42:312–8.
Larner JM, Hahn SS, Spaulding CA, Constable WC. Glomus jugulare tumors. Long-term control by radiation therapy. Cancer 1992;69:1813–7.
Gerosa M, Visca A, Rizzo P, et al. Glomus jugulare tumors: The option of gamma knife radiosurgery. Neurosurgery 2006;59:561–9; discussion 561–569.
Navarro Martin A, Maitz A, Grills IS, et al. Successful treatment of glomus jugulare tumours with gamma knife radiosurgery: Clinical and physical aspects of management and review of the literature. Clin Transl Oncol 2010;12:55–62.
Ioannides PJ, Hansen TM, McDonald MW. Proton and x-ray radiation for head and neck paragangliomas. Int J Part Ther 2015;1:856–65.
Krych AJ, Foote RL, Brown PD, Garces YI, Link MJ. Long-term results of irradiation for paraganglioma. Int J Radiat Oncol Biol Phys 2006;65:1063–6.
Lightowlers S, Benedict S, Jefferies SJ, et al. Excellent local control of paraganglioma in the head and neck with fractionated radiotherapy. Clin Oncol 2010;22:382–9.
Gerber MJ, Mason JC, Lambert PR. Hearing results after primary cartilage tympanoplasty. Laryngoscope 2000;110:1994–9.
Utech H. Tympanotomy in disorders of sound conduction; its diagnostic and therapeutic possibilities [in German]. Z Laryngol Rhinol Otol 1959;38:212–21.
Patnaik U, Prasad SC, Medina M, et al. Long term surgical and hearing outcomes in the management of tympanomastoid paragangliomas. Am J Otolaryngol 2015;36:382–9.
Marchioni D, Villari D, Alicandri-Ciufelli M, Piccinini A, Presutti L. Endoscopic open technique in patients with middle ear cholesteatoma. Eur Arch Otorhinolaryngol 2011;268:1557–63.
Isaacson B, Nogueira JF. Endoscopic management of middle ear and temporal bone lesions. Otolaryngol Clin North Am 2016;49:1205–14.
Fyrmpas G, Tsetsos N, Katotomichelakis M, Rudic M. Lasers in endoscopic middle ear surgery: Where do we stand today? Eur Arch Otorhinolaryngol 2021;278:4169–77.
O'Connell BP, Hunter JB, Carlson ML, et al. Utility of an ultrasonic aspirator in transcanal endoscopic resection of temporal bone paraganglioma. J Neurol Surg B Skull Base 2017;78:96–8.
Noel JE, Sajjadi H. KTP-laser-assisted endoscopic management of glomus tympanicum tumors: A case series. Ear Nose Throat J 2018;97:399–402.
Quick ME, Acharya A, Friedland P, et al. Endoscopic management of early stage middle ear paragangliomas—An Australian case series. Otol Neurotol 2021;42:1677–82.
Forest JA 3rd, Jackson CG, McGrew BM. Long-term control of surgically treated glomus tympanicum tumors. Otol Neurotol 2001;22:232–6.
Mahadevaiah A, Parikh B, Kumaraswamy K. Surgical management of glomus tympanicum tumor. Indian J Otolaryngol Head Neck Surg 2007;59:5–8.
Medina M, Prasad SC, Patnaik U, et al. The effects of tympanomastoid paragangliomas on hearing and the audiological outcomes after surgery over a long-term follow-up. Audiol Neurootol 2014;19:342–50.
Kaul VF, Filip P, Schwam ZG, Wanna GB. Nuances in transcanal endoscopic surgical technique for glomus tympanicum tumors. Am J Otolaryngol 2020;41:102562.